# Impact of Colchicine in Hospitalized Colombian Patients With COVID-19

> **NCT04539873** · PHASE3 · TERMINATED · sponsor: **Fundación Universitaria de Ciencias de la Salud** · enrollment: 128 (actual)

## Conditions studied

- Corona Virus Infection

## Interventions

- **DRUG:** Colchicine 0.5 MG
- **COMBINATION_PRODUCT:** CONTROL GROUP

## Key facts

- **NCT ID:** NCT04539873
- **Lead sponsor:** Fundación Universitaria de Ciencias de la Salud
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2021-04-30
- **Primary completion:** 2021-10-30
- **Final completion:** 2021-10-30
- **Target enrollment:** 128 (ACTUAL)
- **Why stopped:** non-inclusion of patients in the study effectively
- **Last updated:** 2022-02-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04539873

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04539873, "Impact of Colchicine in Hospitalized Colombian Patients With COVID-19". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04539873. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*